Apoptotic Activity of MeCP2 Is Enhanced by C-Terminal Truncating Mutations.
Methyl-CpG binding protein 2 (MeCP2) is a widely abundant, multifunctional protein most highly expressed in post-mitotic neurons. Mutations causing Rett syndrome and related neurodevelopmental disorders have been identified along the entire MECP2 locus, but symptoms vary depending on mutation type a...
Main Authors: | Alison A Williams, Vera J Mehler, Christina Mueller, Fernando Vonhoff, Robin White, Carsten Duch |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4956225?pdf=render |
Similar Items
-
Drosophila as a model for MECP2 gain of function in neurons.
by: Fernando Vonhoff, et al.
Published: (2012-01-01) -
Structural investigation of Rett-inducing MeCP2 mutations
by: Ottavia Spiga, et al.
Published: (2019-03-01) -
MeCP2 and Chromatin Compartmentalization
by: Annika Schmidt, et al.
Published: (2020-04-01) -
MeCP2 repression goes nonglobal
by: Klose, R
Published: (2003) -
Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage
by: Collins BE, et al.
Published: (2022-11-01)